BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND POU2AF1, OBF1, 5450, ENSG00000110777, BOB1, OCAB, Q16633, OBF-1
7 results:

  • 1. Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients.
    Ullah MA; Alam S; Moin AT; Ahamed T; Shohael AM
    Comput Biol Med; 2023 May; 158():106855. PubMed ID: 37040675
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Research into the characteristic molecules significantly affecting liver cancer immunotherapy.
    Chen J; Jin H; Zhou H; Hei X; Liu K
    Front Immunol; 2023; 14():1029427. PubMed ID: 36860864
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Trends and Patterns of Disparities in cancer Mortality Among US Counties, 1980-2014.
    Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
    JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.
    You J; Liu WY; Zhu GQ; Wang OC; Ma RM; Huang GQ; Shi KQ; Guo GL; Braddock M; Zheng MH
    Oncotarget; 2015 Aug; 6(23):19880-90. PubMed ID: 26082438
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.
    Helgestad J; Rosthøj S; Pedersen MH; Johansen P; Iyer V; Østergaard E; Heilmann C
    Pediatr Transplant; 2014 Feb; 18(1):E35-9. PubMed ID: 24168387
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A case of plasmablastic lymphoma of the liver without human immunodeficiency virus infection.
    Tani J; Miyoshi H; Nomura T; Yoneyama H; Kobara H; Mori H; Morishita A; Himoto T; Masaki T
    World J Gastroenterol; 2013 Oct; 19(37):6299-303. PubMed ID: 24115831
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis].
    Teofănescu I; Gologan E; Stefănescu G; Bălan G
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):39-46. PubMed ID: 20509274
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.